Kedudukan dalam Saham
#20461
Onward Medical N.V. is a medical technology company dedicated to developing... Onward Medical N.V. is a medical technology company dedicated to developing innovative therapies for spinal cord injuries, operating both within the Netherlands and internationally. Among its primary offerings is ARCEX, a non-invasive, external platform. This system incorporates a wearable stimulator and a wireless programmer, designed to restore or significantly enhance hand and arm motor function for individuals living with spinal cord injuries. Complementing this is ARCIM, an implantable platform. ARCIM features an implantable pulse generator and a lead positioned near the spinal cord, empowering individuals with chronic paralysis to regain the ability to stand and walk, often with minimal or no external assistance. The company is also currently advancing the Up-LIFT Trial, a clinical study evaluating the safety and efficacy of ARCEX Therapy in restoring strength and mobility in the upper extremities of those affected by spinal cord injury. Established in 2014, Onward Medical N.V. maintains its headquarters in Eindhoven, Netherlands.
Perubahan (1 hari)
-0.42%
Perubahan (1 tahun)
-52.80%
Perdagangan Onward Medical N.V. (ONWD)
Harga ONWD dengan permodalan pasaran b
Modal pasaran bagi Onward Medical N.V.(ONWD)
Modal Pasaran: $130.65M
Sehingga August 2026, Onward Medical N.V. mempunyai modal pasaran sebanyak $130.65M. Ini menjadikan Onward Medical N.V. syarikat ke-20461st paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Onward Medical N.V. dari 2021 hingga 2026
ONWD berbanding dengan 5 teratas yang paling popular stocks
| Harga ONWD |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.211T
|
+3,988,678.00%
|
|
|
|
|
$4.547T
|
+3,479,976.11%
|
|
|
|
|
$4.162T
|
+3,185,856.11%
|
|
|
|
|
$3.593T
|
+2,749,819.44%
|
|
|
|
|
$2.793T
|
+2,137,548.69%
|